Patient perceptions of bioengineered probiotics and clinical metagenomics
Patient perceptions of bioengineered probiotics and clinical metagenomics
批准号:
7908705
负责人:
Ruth Farrell
金额:
$39.81万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-23 至 2012-07-31
关键词:
AddressAreaAttitudeBeliefBenefits and RisksBioethicsBiomedical EngineeringClinicalCommunicationDataDiagnosticEducational InterventionEmerging TechnologiesEthical AnalysisEthicsFutureGastroenterologistGastroenterologyGastrointestinal DiseasesHealthHealth PersonnelHealth PolicyHuman MicrobiomeLifeMetabolicMetagenomicsModalityModelingNeonatalPatient CarePatient advocacyPatientsPerceptionPerinatalPhysiciansProbioticsRequest for ApplicationsResearchResearch Project GrantsSocietiesSurveysTechnologyTherapeuticTherapeutic InterventionTimeTransplantationUnited States National Institutes of Healthclinical applicationethical legal social implicationevidence baseimprovedinterestmicrobiomenew technologynovel therapeuticspopulation basedpublic health relevanceresearch studysocialvoluntary health organizationworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The launch of the Human Microbiome Project (HMP), and the corresponding interest in bioengineered probiotic therapies that this new NIH initiative is likely to generate, provide a unique opportunity for research examining ethical and social considerations in the introduction of new therapeutic modalities. To date, analysis of ethical and social considerations in the use of probiotics have focused on "over the counter" applications where physician involvement in the selection and administration of the probiotic is limited. As new probiotic therapies become a part of the clinician's arsenel, it is important to consider how patients may perceive and respond to new probiotic therapies that are recommended by their physicians. To be successfully integrated into patient care, it is critical that patient attitudes and beliefs regarding bioengineered probiotics be well characterized. Studies of patient perceptions of therapeutic probiotics may reveal common misconceptions about probiotic therapies and/or widespead concerns that may limit patient enthusiasm for new therapeutic options. This research project will characterize patient perceptions of bioengineered probiotics and other potential clinical applications of metagenomic analyses of the human microbiome. Empirical results from the project will be presented to a Working Group of national experts in gastroenterology, biomedical ethics, health policy, and patient advocacy, who will identify opportunities to promote the responsible introduction of bioengineered probiotics into the care of patients with debilitating gastrointestinal diseases. These strategies will focus on potential health-policy initiatives and educational interventions that gastroenterologists, patient educators, and voluntary-health organizations can undertake now in anticipation of the time when bioengineered probiotic therapies may be appropriate for routine clinical use. PUBLIC HEALTH RELEVANCE: This research study will examine patient perceptions of bioengineered probiotics and other potential clinical applications of metagenomic analyses of the human microbiome. Systematic data on patient attitudes and beliefs about emerging therapeutic interventions facilitated by the Human Microbiome Project are critically important, as these data can identify potential barriers to the successful integration of bioengineered probiotics into patient care and improve physician-patient communication about new therapeutic options.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/ajg.2008.68
发表时间:
2009-04
期刊:
AMERICAN JOURNAL OF GASTROENTEROLOGY
影响因子:
9.8
作者:
[Sharp, Richard R., Achkar, Jean-Paul, Brinich, Margaret A., Farrell, Ruth M.]
通讯作者:
Farrell, Ruth M.
'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics.
“应该有人监督”:患者对益生菌监管所产生的伦理问题的看法。
DOI:
10.1111/hex.12027
发表时间:
2015
期刊:
Health expectations : an international journal of public participation in health care and health policy
影响因子:
--
作者:
[Harrison,KristaL, Farrell,RuthM, Brinich,MargaretA, Highland,Janelle, Mercer,MaryBeth, McCormick,JenniferB, Tilburt,Jon, Geller,Gail, Marshall,Patricia, Sharp,RichardR]
通讯作者:
Sharp,RichardR
DOI:
10.1080/21507716.2012.662574
发表时间:
2012-07-01
期刊:
AJOB primary research
影响因子:
--
作者:
[Harrison KL, Geller G, Marshall P, Tilburt J, Mercer M, Brinich MA, Highland J, Farrell RM, Sharp RR]
通讯作者:
Sharp RR
Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)
-
批准号:10408663
-
项目类别:
-
资助金额:$60.41万
-
财政年份:2021
-
负责人:Ruth Farrell
-
依托单位:
Supplement to Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)
-
批准号:10593247
-
项目类别:
-
资助金额:$15.12万
-
财政年份:2021
-
负责人:Ruth Farrell
-
依托单位:
Framework for Advances in Reprogenomics Ethics & Regulation (FAIRER)
-
批准号:10596652
-
项目类别:
-
资助金额:$58.61万
-
财政年份:2021
-
负责人:Ruth Farrell
-
依托单位:
Admin. Supplement to: Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
-
批准号:10165356
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2017
-
负责人:Ruth Farrell
-
依托单位:
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
-
批准号:9751355
-
项目类别:
-
资助金额:$62.18万
-
财政年份:2017
-
负责人:Ruth Farrell
-
依托单位:
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes
-
批准号:10658430
-
项目类别:
-
资助金额:$81.58万
-
财政年份:2017
-
负责人:Ruth Farrell
-
依托单位:
Preparing for Emerging Applications of Noninvasive Prenatal Testing
-
批准号:8871291
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2015
-
负责人:Ruth Farrell
-
依托单位:
Patient perceptions of bioengineered probiotics and clinical metagenomics
-
批准号:7572423
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2008
-
负责人:Ruth Farrell
-
依托单位:
Patient perceptions of bioengineered probiotics and clinical metagenomics
-
批准号:7690965
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2008
-
负责人:Ruth Farrell
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: